<?xml version='1.0' encoding='utf-8'?>
<document id="9744552"><sentence text="An evaluation of the cytochrome P450 induction potential of pantoprazole in primary human hepatocytes."><entity charOffset="60-72" id="DDI-PubMed.9744552.s1.e0" text="pantoprazole" /></sentence><sentence text="Primary human hepatocytes contain a full complement of human drug-metabolizing enzymes and therefore represent a relevant experimental system for the evaluation of pharmacokinetic drug-drug interaction potential in human" /><sentence text=" In this study, the cytochrome P450 (CYP) induction potential of pantoprazole (PAN) was evaluated and compared to two other proton pump inhibitors (PPIs), omeprazole (OM) and lansoprazole (LAN)"><entity charOffset="65-77" id="DDI-PubMed.9744552.s3.e0" text="pantoprazole" /><entity charOffset="79-82" id="DDI-PubMed.9744552.s3.e1" text="PAN" /><entity charOffset="155-165" id="DDI-PubMed.9744552.s3.e2" text="omeprazole" /><entity charOffset="167-169" id="DDI-PubMed.9744552.s3.e3" text="OM" /><entity charOffset="175-187" id="DDI-PubMed.9744552.s3.e4" text="lansoprazole" /><entity charOffset="189-192" id="DDI-PubMed.9744552.s3.e5" text="LAN" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e0" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e1" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e3" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e4" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e0" e2="DDI-PubMed.9744552.s3.e5" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e1" e2="DDI-PubMed.9744552.s3.e1" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e1" e2="DDI-PubMed.9744552.s3.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e1" e2="DDI-PubMed.9744552.s3.e3" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e1" e2="DDI-PubMed.9744552.s3.e4" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e1" e2="DDI-PubMed.9744552.s3.e5" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e2" e2="DDI-PubMed.9744552.s3.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e2" e2="DDI-PubMed.9744552.s3.e3" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e2" e2="DDI-PubMed.9744552.s3.e4" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e2" e2="DDI-PubMed.9744552.s3.e5" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e3" e2="DDI-PubMed.9744552.s3.e3" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e3" e2="DDI-PubMed.9744552.s3.e4" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e3" e2="DDI-PubMed.9744552.s3.e5" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e4" e2="DDI-PubMed.9744552.s3.e4" /><pair ddi="false" e1="DDI-PubMed.9744552.s3.e4" e2="DDI-PubMed.9744552.s3.e5" /></sentence><sentence text=" Primary human hepatocytes from three donors were studied" /><sentence text=" The hepatocytes were cultured for 3 days, followed by treatment for 3 days with the PPIs at 2, 5 and 10 microM" /><sentence text=" Two other known CYP inducers, 3-methylcholanthrene at 1 microM and rifampin at 50 microM, were also evaluated"><entity charOffset="31-51" id="DDI-PubMed.9744552.s6.e0" text="3-methylcholanthrene" /><entity charOffset="68-76" id="DDI-PubMed.9744552.s6.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.9744552.s6.e0" e2="DDI-PubMed.9744552.s6.e0" /><pair ddi="false" e1="DDI-PubMed.9744552.s6.e0" e2="DDI-PubMed.9744552.s6.e1" /></sentence><sentence text=" Induction potentials of these chemicals for CYP1A and CYP3A were evaluated by isozyme activity and isozyme content" /><sentence text=" 7-Ethoxyresorufin-O-deethylase and testosterone 6beta-hydroxylase activities were used as endpoints for CYP1A and CYP3A, respectively" /><sentence text=" Isozyme protein contents of CYP1A and CYP3A were evaluated via Western blotting" /><sentence text=" The results showed that for CYP1A induction, the rank ordering in induction potential was consistently OM &gt; LAN &gt; PAN"><entity charOffset="115-122" id="DDI-PubMed.9744552.s10.e0" text="PAN" /><entity charOffset="104-111" id="DDI-PubMed.9744552.s10.e1" text="OM" /><entity charOffset="109-116" id="DDI-PubMed.9744552.s10.e2" text="LAN" /><pair ddi="false" e1="DDI-PubMed.9744552.s10.e1" e2="DDI-PubMed.9744552.s10.e1" /><pair ddi="false" e1="DDI-PubMed.9744552.s10.e1" e2="DDI-PubMed.9744552.s10.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s10.e1" e2="DDI-PubMed.9744552.s10.e0" /><pair ddi="false" e1="DDI-PubMed.9744552.s10.e2" e2="DDI-PubMed.9744552.s10.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s10.e2" e2="DDI-PubMed.9744552.s10.e0" /></sentence><sentence text=" CYP3A induction by the PPI's were observed in two of the three hepatocyte cultures, with no apparent differences in induction potency for the three compounds" /><sentence text=" Our results on CYP1A induction suggest that PAN has a lower drug-drug interaction potential than OM and LAN"><entity charOffset="45-47" id="DDI-PubMed.9744552.s12.e0" text="PAN" /><entity charOffset="98-100" id="DDI-PubMed.9744552.s12.e1" text="OM" /><entity charOffset="105-107" id="DDI-PubMed.9744552.s12.e2" text="LAN" /><pair ddi="false" e1="DDI-PubMed.9744552.s12.e0" e2="DDI-PubMed.9744552.s12.e0" /><pair ddi="false" e1="DDI-PubMed.9744552.s12.e0" e2="DDI-PubMed.9744552.s12.e1" /><pair ddi="false" e1="DDI-PubMed.9744552.s12.e0" e2="DDI-PubMed.9744552.s12.e2" /><pair ddi="false" e1="DDI-PubMed.9744552.s12.e1" e2="DDI-PubMed.9744552.s12.e1" /><pair ddi="false" e1="DDI-PubMed.9744552.s12.e1" e2="DDI-PubMed.9744552.s12.e2" /></sentence><sentence text="" /></document>